Mn Services Vermogensbeheer B.V. Horizon Therapeutics Public LTD CO Transaction History

Mn Services Vermogensbeheer B.V.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$98.98 - $115.74 $296,940 - $347,220	3,000 Added 2.9%	106,300 $12.3 Million
Q2 2023 Aug 09, 2023	SELL	$96.34 - $112.38 $279,386 - $325,902	-2,900 Reduced 2.73%	103,300 $10.6 Million
Q1 2023 Apr 26, 2023	BUY	$107.32 - $113.5 $354,156 - $374,550	3,300 Added 3.21%	106,200 $11.6 Million
Q4 2022 Feb 03, 2023	SELL	$62.39 - $113.8 $1.05 Million - $1.91 Million	-16,800 Reduced 14.04%	102,900 $11.7 Million
Q3 2022 Nov 01, 2022	SELL	$58.92 - $84.67 $412,440 - $592,690	-7,000 Reduced 5.52%	119,700 $7.41 Million

Q2 2022 Aug 03, 2022	SELL	$79.4 - $116.36 $2.13 Million - $3.12 Million	-26,800 Reduced 17.46%	126,700 $10.1 Million
Q1 2022 May 10, 2022	SELL	$86.42 - $109.81 $950,620 - $1.21 Million	-11,000 Reduced 6.69%	153,500 $16.2 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $670,208 - $815,388	6,800 Added 4.31%	164,500 $17.7 Million
Q3 2021 Nov 03, 2021	BUY	$91.91 - $110.37 $147,056 - $176,592	1,600 Added 1.02%	157,700 $17.3 Million
Q2 2021 Aug 05, 2021	BUY	$86.24 - $95.92 $13.5 Million - $15 Million	156,100 New	156,100 $12.3 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.